Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Yang%2C+James+Chih-Hsin%22&type=Person&filter%5B%5D=journalStr%3A%22Journal+of+thoracic+oncology+%3A+official+publication+of+the+International+Association+for+the+Study+of+Lung+Cancer%22
/vufind/Search/Results?lookfor=%22Yang%2C+James+Chih-Hsin%22&type=Person&filter%5B%5D=journalStr%3A%22Journal+of+thoracic+oncology+%3A+official+publication+of+the+International+Association+for+the+Study+of+Lung+Cancer%22
Search /vufind/Search2/Results?lookfor=%22Yang%2C+James+Chih-Hsin%22&type=Person&filter%5B%5D=journalStr%3A%22Journal+of+thoracic+oncology+%3A+official+publication+of+the+International+Association+for+the+Study+of+Lung+Cancer%22
PubPharm (40)
1
Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC : Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2024
von
Reck, M.
|
Barlesi, F.
|
Yang, J.
| +15
Wird geladen...
2
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007) : A Randomized, Double-Blind, Phase 3 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2023
von
Yang, J.
|
Han, B.
|
De La Mora Jiménez, E.
| +16
Wird geladen...
3
Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib : Results of Phase 3 ALTA-3 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2023
von
Yang, J.
|
Liu, G.
|
Lu, S.
| +11
Wird geladen...
4
Central Nervous System Outcomes of Lazertinib Versus Gefitinib in EGFR-Mutated Advanced NSCLC : A LASER301 Subset Analysis
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2023
von
Soo, R.
|
Cho, B.
|
Kim, J.
| +20
Wird geladen...
5
Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2023
von
Mitsudomi, T.
|
Tan, D.
|
Yang, J.
| +14
Wird geladen...
6
Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors : Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2022
von
Lin, E.
|
Hsu, C.
|
Chiou, J.
| +7
Wird geladen...
7
Lung Cancer in Republic of China
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2021
von
Luo, Y.
|
Chiu, C.
|
Scott Kuo, C.
| +9
Wird geladen...
8
Long-Term Overall Survival From KEYNOTE-021 Cohort G : Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2021
von
Awad, M.
|
Gadgeel, S.
|
Borghaei, H.
| +15
Wird geladen...
9
Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC : A Multicenter, Open-label, Phase 1 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2020
von
Yang, J.
|
Camidge, D.
|
Yang, C.
| +26
Wird geladen...
10
Afatinib for the Treatment of NSCLC Harboring Uncommon EGFR Mutations : A Database of 693 Cases
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2020
von
Yang, J.
|
Schuler, M.
|
Popat, S.
| +5
CommentIn: J Thorac Oncol. 2020 May;15(5):681-685. - PMID 32340673
Wird geladen...
1
2
3
4
Nächster »
[4]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Medienart
40
Aufsätze
40
E-Artikel
40
E-Ressourcen
Zeitschriftentitel
Journal of thoracic oncology : official publica...
Thema
36
Journal Article
24
Research Support, Non-U.S. Gov't
23
EC 2.7.10.1
19
ErbB Receptors
15
EGFR protein, human
15
Protein Kinase Inhibitors
12
Randomized Controlled Trial
11
Multicenter Study
10
NSCLC
9
Antineoplastic Agents
9
Non–small cell lung cancer
8
Clinical Trial, Phase III
7
Gefitinib
7
Quinazolines
7
S65743JHBS
6
Clinical Trial, Phase II
6
EGFR mutation
5
04Q9AIZ7NO
5
3C06JJ0Z2O
5
Acrylamides
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
12
2020-
28
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
40
Englisch
Haven't found what you're looking for?
Wird geladen...